Announced
Completed
Financials
Sources
Tags
Friendly
India
Therapy
Health Care Services
Domestic
Acquisition
Majority
Private
Completed
Single Bidder
Synopsis
Lupin, a multinational pharmaceutical company, completed the acquisition of five legacy brands from Menarini, a biopharmaceutical company for $12.27m. “This acquisition aligns well with our strategic goal to broaden our presence in the Indian market. By offering a comprehensive range of products, our aim is to deliver even greater value to our stakeholders and the communities we serve,” Nilesh Gupta, Lupin Managing Director.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.